Home › Cutis Laxa
Cutis Laxa clinical trials recruiting in the U.S.
9 studies for Cutis Laxa are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
RecruitingHealthy volunteers welcome
Ages 30 to 60 · All sexes · Updated Aug 26, 2026 · NCT07187297Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
RecruitingHealthy volunteers welcome
Ages 18 to 85 · All sexes · Updated Apr 23, 2026 · NCT05750901Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue
RecruitingHealthy volunteers welcome
Ages 30 to 65 · All sexes · Updated Apr 20, 2026 · NCT07229430A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
Recruiting
Ages 45 to 65 · Women · Updated Feb 10, 2026 · NCT07399028Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists
RecruitingObservational study
Ages 30 to 65 · All sexes · Updated Dec 31, 2025 · NCT07224880Long-Term Efficacy and Duration of MFU-V at Multiple Depths and at 1.5 mm
RecruitingHealthy volunteers welcome
Ages 25 to 65 · All sexes · Updated Nov 4, 2025 · NCT07224308Pure Impact Treatment to Strengthen and Tone Abdomen, Quadriceps and Glutes Muscles
RecruitingHealthy volunteers welcome
Ages 25 to 60 · All sexes · Updated Aug 3, 2025 · NCT07094971Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators
RecruitingHealthy volunteers welcome
Ages 35 to 80 · All sexes · Updated May 13, 2025 · NCT06333067Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles
RecruitingHealthy volunteers welcome
Ages 40 to 70 · All sexes · Updated Jan 4, 2019 · NCT03793348From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.